This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mammography World Markets

Figure A6.9: Chemotherapy Use among Leukemia Patients by Age 171

Figure A6.10: Non-Hodgkin Lymphoma Treatment Patterns 172

Figure A6.11: Distribution (%) of Lung and Bronchus Cancer by Race and Stage at Diagnosis 173

Figure A6.12: Non-Small Cell Lung Cancer Treatment Patterns by Stage 174

Figure A6.13: Five-Year Survival Rates for Lung and Bronchus Cancer Patients by Race and Stage 175

Figure A6.14: Distribution (%) of Melanoma by Race and Stage 175

Figure A6.15: Five-Year Survival Rates for Melanoma Patients by Race and Stage 176

Figure A6.16: Distribution of Prostate Cancer by Race and Stage 177

Figure A6.17: Prostate Cancer Primary Treatment Patterns by Age 178

Figure A6.18: Five-Year Survival Rates for Prostate Patients by Race and Stage 179

Figure A6.19: Distribution of Testicular Cancer by Race and Stage 179

Figure A6.20: Treatment Patterns for Testicular Cancer Patients 180

Figure A6.21: Treatment Patterns for Non-Seminomatous Testicular Cancer 181

Figure A6.22: Five-Year Survival Rates for Testicular Cancer Patients by Race and Stage 181

Figure A6.23: Distribution of Thyroid Cancer by Race and Stage 182

Figure A6.24: Five-Year Survival Rates for Thyroid Cancer Patients by Race and Stage 183

Figure A6.25: Distribution of Urinary Bladder Cancer by Race and Stage 184

Figure A6.26: Muscle Invasive Bladder Cancer Treatment Patterns 184

Figure A6.27: Five-Year Survival Rates for Urinary Bladder Cancer Patients by Race and Stage 185

Figure A6.28: Distribution of Uterine Corpus Cancer by Race and Stage 186

Figure A6.29: Uterine Cancer Treatment Patterns by Stage 186

Figure A6.30: Five-Year Survival Rates for Uterine Corpus Cancer Patients by Race and Stage 187

Figure A6.31: Domains of Quality of Life 193

Figure A6.32: Observed-to-Expected Ratios for Subsequent Cancers by Site, Sex

and Age 20 and Older 196

Figure A6.33: Observed-to-Expected Ratios for Subsequent Cancers by Primary Site 198

Figure A6.34: Unmet Caregiver Needs by Time Since Diagnosis 199

11 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs